(Israel21c via JNS) — About 120 research groups from various countries are racing to develop vaccines for the SARS-CoV-2 virus (COVID-19). Several formulations have already advanced to human safety trials. Although the frontrunners in this race are American, British, Chinese, Japanese and German, Israel also has a few contenders.
However, vaccine development, like drug development, is a long and complicated process. And it doesn’t always succeed, explains industry expert Ron Ellis, editor in chief of “Human Vaccines & Immunotherapeutics” and a vaccine development consultant.
“In 1984, the U.S....
Reader Comments(0)